Clinical Trials Browser

OTHER × Urologic Neoplasms × lenvatinib × Clear all

NCT02915172 2017-06-26

Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Phase 1 Withdrawn

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms